Jolena M. Zabel

Associate

ミネアポリス + 1.612.217.8930

Connect:

共有

Jolena Zabel represents corporations and individuals in high-stakes complex civil and criminal litigation, enforcement actions, and investigations. Her recent litigation and investigative experience includes claims involving professional liability, business torts and contract disputes, antitrust, state labor laws, the False Claims Act (FCA), the Foreign Corrupt Practices Act (FCPA), and the federal Controlled Substances Act (CSA).

Jolena has represented clients in the health care, pharmaceutical, retail, and financial industries. She is experienced in all aspects of litigation and investigations, including fact investigation, witness interviews, drafting and responding to discovery, e-discovery, depositions, expert witnesses, motions practice, and trial.

As part of her active pro bono practice, Jolena represents clients in immigration proceedings, including successfully obtaining bond and habeas relief for detained immigrants.

Jolena previously served as a judicial law clerk at the Minnesota Supreme Court. Prior to becoming a lawyer, Jolena worked at an international nonprofit organization in Washington, D.C.

担当案件

  • Allina Health obtains complete defense verdict in malpractice caseJones Day obtained a full defense verdict in a malpractice case on behalf of Allina Health System, one of the largest non-profit health systems in Minnesota.
  • Maxeon Solar Technologies completes public offering of $241.2 million of Ordinary Shares and concurrent private placement of $42 million of Ordinary SharesJones Day represented Maxeon Solar Technologies, Ltd., one of the world’s leading global manufacturers and marketers of premium solar power technology, in a public offering of 8,613,500 Ordinary Shares, consisting of 5,620,000 Ordinary Shares offered by Maxeon and 2,993,500 Ordinary Shares offered by an affiliate of TotalEnergies SE, one of Maxeon’s existing shareholders.
  • Ecolab completes $500 million public offering of NotesJones Day represented Ecolab Inc. in connection with its underwritten public offering of $500 million aggregate principal amount of 5.250% Notes due 2028.
    •

    送信する前の注意事項：

    www.jonesday.comに掲載されている情報は、一般的な使用を目的としており、法的アドバイスを目的としたものではありません。このEmailを送信することにより、弁護士を含む専門家・依頼者の関係を構築することを意図するものではなく、このEmailの受領はそのような関係を構築するものではありません。当事務所に送信されたいかなる情報も、業務委託契約を結ばない限り、弁護士等が依頼者に対して守秘義務を負う機密事項として取り扱われることはありません。このEmailの送信者は以上の注意事項の内容を読み、理解したものと判断します。